American Antibiotics

Strategy

With continued commitment to our core values, American Antibiotics will expand its product offerings through the execution of its Research and Development strategy. The company has numerous ANDA products in various stages of development.

The company has an aggressive product development pipeline Including new drug applications 505(b)(2) applications, abbreviated new drug applications (“ANDAs”) with over five products in various stages of development and contract manufacturing services for a multitude of different pharmaceutical companies. American Antibiotics product development initiatives are led by its in-house team of drug development experts. 

  • Provide outstanding customer service with a focus on cost saving and profitability.
  • Focus on difficult to manufacture products
  • Manufacture and develop niche products
  • Develop high-potential unique products
  • Consistently be first or second to market with products
  • Develop new 505(b)(2) and ANDA products
  • In-License and Out-License Product
Our Advantage
  • Quality. We manufacture a wide range of superior products - from tablets and capsules to powders, suspensions and injectibles- using the most advanced equipment at our modern facilities.
  • Flexibility. We customize product formulations and packaging configurations in both small and large volumes to meet every customer's individual needs.
  • Reliability. We provide on-time delivery, exceptional service and competitive pricing, helping our customers bring world-class products to millions of consumers globally.